|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
103.26(B) |
Last
Volume: |
6,021,087 |
Avg
Vol: |
8,469,733 |
52
Week Range: |
$48.64 - $73.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
96,581 |
377,614 |
901,711 |
1,862,313 |
Total Sell Value |
$6,534,949 |
$22,111,166 |
$49,794,655 |
$91,194,728 |
Total People Sold |
6 |
8 |
11 |
13 |
Total Sell Transactions |
10 |
20 |
37 |
70 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Carruthers Wendy |
EVP, Human Resources |
|
2023-04-17 |
4 |
OE |
$13.08 |
$94,954 |
D/D |
6,408 |
95,044 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-04-05 |
4 |
AS |
$50.40 |
$247,111 |
D/D |
(4,903) |
78,673 |
|
2% |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-03-23 |
4 |
AS |
$47.97 |
$321,543 |
D/D |
(6,703) |
22,981 |
|
6% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-03-15 |
4 |
AS |
$47.60 |
$555,575 |
D/D |
(11,671) |
88,636 |
|
9% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-03-15 |
4 |
OE |
$13.08 |
$94,954 |
D/D |
6,408 |
100,307 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2023-03-02 |
4 |
AS |
$46.66 |
$1,399,914 |
D/D |
(30,000) |
225,958 |
|
11% |
|
Brennan Daniel J. |
EVP and CFO |
|
2023-03-01 |
4 |
AS |
$46.64 |
$3,526,337 |
D/D |
(75,610) |
255,958 |
|
12% |
|
Brennan Daniel J. |
EVP and CFO |
|
2023-03-01 |
4 |
OE |
$13.08 |
$715,794 |
D/D |
45,610 |
331,568 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2023-03-01 |
4 |
AS |
$46.66 |
$233,315 |
D/D |
(5,000) |
34,868 |
|
12% |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2023-03-01 |
4 |
OE |
$12.89 |
$64,450 |
D/D |
5,000 |
39,868 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-22 |
4 |
AS |
$46.10 |
$153,974 |
D/D |
(3,340) |
88,479 |
|
15% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-21 |
4 |
D |
$46.23 |
$88,900 |
D/D |
(1,923) |
220,277 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,895 |
222,200 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2023-02-21 |
4 |
D |
$46.23 |
$10,587 |
D/D |
(229) |
41,651 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
779 |
41,880 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2023-02-21 |
4 |
D |
$46.23 |
$11,650 |
D/D |
(252) |
34,868 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
623 |
35,120 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-02-21 |
4 |
D |
$46.23 |
$35,181 |
D/D |
(761) |
29,684 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
30,445 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-21 |
4 |
AS |
$46.32 |
$107,138 |
D/D |
(2,313) |
91,819 |
|
17% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-21 |
4 |
D |
$46.23 |
$59,128 |
D/D |
(1,279) |
94,132 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,804 |
95,411 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-21 |
4 |
D |
$46.23 |
$45,906 |
D/D |
(993) |
64,982 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
65,975 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-02-21 |
4 |
D |
$46.23 |
$31,945 |
D/D |
(691) |
93,899 |
|
- |
|
2518 Records found
|
|
Page 9 of 101 |
|
|